COHEN PONTANI LIEBERMAN & PAVANE LLP
www.cplplaw.com
 
Library
Articles | Lectures | Decisions | Press Releases
 
Articles
  • Ask the Expert: Concerns About Patent Rule Changes, Electronic Business by Edward Weisz, Partner
  • Ask the Expert: Did Broadcom act unethically concerning Bluetooth?, Electronic Business by Alfred Froehbrich, Partner
  • Ask the Expert: Is it Better to Brand or Patent IP?, Electronic Business by Edward Weisz, Partner
  • Analysis of Selection Invention with Examples, INVENTION & INNOVATION 2003 (7), by Enshan Hong, Wei Li, Daoyi Bi, Xiaoling Peng
    例析选择发明 洪恩山 李微 毕道毅 彭晓玲 《发明与创新》 2003年 第7期
  • Analysis of Selection Invention, INVENTION & INNOVATION 2003 (2), by Enshan Hong, Wei Li
    试析选择发明 洪恩山 李微 《发明与创新》 2003年 第2期
  • Biosimilars in the United States - a Brief Look at Where We Are and the Road Ahead, Biotechnology Law Report - Expert Analysis of Current Developments by Alan J. Morrison, Partner
  • Business Methods and Software Patents in the United States, Peking University Intellectual Property Review, Vol. 2, p. 350 by Edward Weisz, Partner & Roger Thompson, Associate
  • Commentary: Supreme Court Update - KSR v. Teleflex and the Determination of Obviousness, by Alfred Froebrich, Partner & Alan Morrison, Partner
  • Das US-Gesetz ueber Arzneimittelpreiswettbewerb und Patent ..., Teil I, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner
  • Das US-Gesetz ueber Arzneimittelpreiswettbewerb und Patent ..., Teil II, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner
  • The Drug Price Competition and Patent Term Restoration Act - 10 Years Later, Part I, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner
  • The Drug Price Competition and Patent Term Restoration Act - 10 Years Later, Part II, Mitteilungen der deutschen Patentanwälte by Thomas Pontani, Partner
  • Foreign Infringment of US Patents, Managing Intellectual Property by Edward M Weisz, Partner
  • Geron's Giant Leap, Forbes, by Lisa LaMotta with Kent Cheng, Partner
  • How Seagate has reshaped patent litigation practices, Managing Intellectual Property by William Alper, Partner
  • International Briefing - An Anti-Cybersquatting Case Study, Managing Intellectual Property by Lisa A. Ferrari, Partner
  • International Briefing - Bilski and Business Methods, Managing Intellectual Property by Julia S. Kim, Partner
  • International Briefing - How to Avoid Errors of Inventorship, Managing Intellectual Property by Lisa A. Ferrari, Partner
  • International Briefing - How to Determine and Correct Inventorship, Managing Intellectual Property by Edward Weisz, Partner, and Mher Hartoonian, Associate
  • International Briefing - Litigation - Entire Market Clarified, Managing Intellectual Property by Edward DiLello, Senior Counsel
  • International Briefing - Keep It Candid at the USPTO, Managing Intellectual Property by William A. Alper, Partner
  • International Briefing - Patenting DNA in the U.S., Managing Intellectual Property by Alan Morrison, Partner
  • International Briefing - When Foreign Infringement Signals Litigation, Managing Intellectual Property by Edward Weisz, Partner & Mher Hartoonian, Associate
  • IP101: How to Legally Protect Your Semiconductor Products, Electronic Business by Thomas Langer, Partner
  • IP Expert Advice: How do I track the status of a patent if the company is defunct?, EDN-Electronic Business by Edward Weisz, Partner
  • IP Expert Advice: How to determine and correct inventorship in U.S. patents, EDN-Electronic Business by Edward Weisz, Partner & Mher Hartoonian, Associate
  • IP Expert Advice: Tips on creating a lab notebook that contains "convincing evidence", EDN-Electronic Business by Lance Lieberman, Partner
  • IP Expert Advice: U.S. inventorship and priority disputes over geography, EDN-Electronic Business by Mher Hartoonian, Associate & Edward Weisz, Partner
  • Know Your Knockoffs - How patents can protect lighting manufacturers, Residential Lighting by Edward Weisz, Partner
  • Patents: Don't Change the Landscape Too Quickly, Bank Systems &Technology by Alan Tenenbaum, Partner
  • Patents for Medical Devices and Avoiding Infringement, Medical Design by Edward Weisz, Partner
  • Potential Competition: An Idea Whose Time Has Passed, Brooklyn Law Review by William A. Alper, Partner
  • Practicing The Prior Art under Chinese Patent Law, INVENTION & INNOVATION 2010 (3) by Enshan Hong, Associate
    中国专利法中的现有技术抗辩制度之探讨 洪恩山《中国发明与专利》2010年第3期
  • Preventing Loss of Right to Patent – A Summary of U.S. Statutory Bars to Patentability, Vol 2 Peking University Intellectual Property Review by Edward Weisz, Partner & Richard Margiano, Associate
  • Protecting Intellectual Property, Motion System Design by Martin Pavane, Partner & Richard Margiano, Associate
  • Protecting Pharmaceutical Products, Processes and R&D from Competitive Challenges, Pharmaceutical Technology Magazine by Michael Stuart, Partner
  • Recapturing R&D Leadership - Industry Week Cover Story with Lance Lieberman, Partner
  • Special Report: Securing Intellectual Property, Avionics by Martin Pavane, Partner & Richard Margiano, Associate
  • Supreme Court debates critical component, by Shanaz Mahmud, Reporter, Managing Intellectual Property with Kent Cheng, Partner
  • Will Apple Patents Banish HTC Phones, by Jared Newman, Reporter, PCWorld with Alan Tenebaum, Partner
    •  

    Lectures
  • “Biosimilars in the United States: An Update”, presented at Biosimilars 2007, organized by Visiongain, London, United Kingdom, December 6, 2007 by Alan Morrison, Partner
  • “Challenging the Biotech Patent: The ACLU Takes on Myriad Genetics and the U.S. Patent Office,” presented at Fundamentals of the Bioscience Industry, Center for Biotechnology, New York, New York, February 9, 2010 Alan Morrison, Partner - Lecturer
  • “Defending IP in the U.S.”, presented at the Sixth Annual Asia-Pacific Intellectual Property Forum in Hong Kong, September 2009 - by Edward M. Weisz and Martin B. Pavane, Partners
  • “Drafting a Patent Application that Can Withstand Litigation,” Beijing, China by Kent Cheng, Partner
  • “Ethical Issues Concerning Human Embryonic Stem Cell Patents,” presented at the Second Annual Meeting of The Stem Cell Partnering Series, held at the University of California, San Diego, February 27, 2009, by Alan Morrison, Partner (Lecturer and Meeting Co-Chair)
  • Global Plastics Environmental Conferences, Detroit, Michigan on general topics concerning U.S. patent law by Edward Weisz, Partner
  • “International Digital Rights Developments, Digital Rights: Protecting Your Client's Rights Under Current Regulatory & Marketplace Developments,” Association of the Bar of the City of New York by Richard Margiano
  • “Legal Hurdles and Strategies in Building a University Biotech Portfolio,” presented as part of the panel on Building a Strong University Biotech Patent Portfolio, held at the 2008 Life Sciences Industry Summit, Long Island, New York, by Alan Morrison, Partner
  • Peking University, Intellectual Property Law Institute (Beijing, China, 2004 & 2005), on various U.S. patent and trademark law topics by Edward Weisz, Partner
  • “Selected Topics in U.S. Biotech Patent Law” presented at the Workshop on Biotechnology Patent Law, hosted by Michalski Hüttermann and Alan J. Morrison, Partner, Düsseldorf, Germany, May 5, 2009 - by Alan J. Morrison, Partner
  • “Should Genes Be Patented?,” a panel discussion with Dr. Wendy Chung, Alan J. Morrison, Esq. and Dr. John Loike, presented at Columbia University and hosted by Columbia Technology Ventures, New York, New York, April 28, 2010 (Panelist)
  • “Understanding, Prosecuting and Enforcing Biotech and Pharmaceutical Patents in the United States,” presented at the 2007 IP Workshop for Biotech Pharmaceutical Industry (Including Generic Drug Entry in the US), held under the auspices of the Center for Drug Evaluation, Taipei, Taiwan, April 2, 2007, by Alan Morrison, Partner
  • “Understanding the US Biotechnology Patent”, presented at Sun Yat-Sen University, Guangzhou, China June 16, 2009 by Alan J. Morrison, Partner
  • “Understanding the Biotechnology Patent,” presented to the Master’s Program in Biotechnology, Columbia University, New York, New York, March 11, 2009, by Alan Morrison, Partner
  • “U.S. trademark law”, presented at Beijing Institute of Technology (Beijing, China, 2005), by Edward Weisz, Partner
  • “What Price Biosimilars? Balancing the Innovation and Cost of Biologics in America”, presented at Biologic India 2009, Mumbai, India, December 2, 2009, by Alan Morrison, Partner


    •  

    Decisions
  • Metso Minerals, Inc v Powerscreen Intl. Distribution Ltd, Terex Corp, Powerscreen New York Inc, Emerald Equipment Systems, Inc Case No 06-cv-1446 (ADS)(E)(January 28, 2010)
  • Newport News Holding Corp. v. Virtual City Vision, Inc., and Van James Bond Tran., Final Order. Case No. 4:08-cv-0019-FBS (E.D. Va. July 27, 2009).
  • Altana Pharma AG and Wyeth v. Teva Pharmaceuticals Industries LTD and SUN PHARMACEUTICAL INDUSTRIES, LTD., U.S. Court of Appeals for the Federal Circuit, 2008-1039, 566 F.3d 999 (May 13, 2009).
  • Newport News Holdings Corp. v. Virtual City Vision, Inc., et al., Case No. 4:08-cv-00019 (E.D. Va. Feb. 3, 2009).
  • Inter parties rexamination on behalf of Gladerma R&D of Leo Pharmaceutical Products Ltd., US Patent No. 6,753,013 for TACLONEX (August 2008)
  • The Pomeroy Collection, LTD. v. Kirkland’s Inc. & Home Essentials & Beyond, Inc., No. SACY 08-0635; AG (US Dist. June 13, 2008).
  • Pharm.Res., Inc. and Par Pharm., Inc. v. Roxane Labs., Inc., U.S. Court of Appeals for the Federal Circuit, 2007-1093, - 1134 (Fed. Cir. October 26, 2007).
  • In re Metoprolol Succinate Patent Litigation, No. 2006-1254 (Fed. Cir. July 23, 2007).
  • Westrex Corp. v. New Sensor Corp., 83 U.S.P.Q.2d 1215 (T.T.A.B. May 11, 2007).
  • Savient Pharmaceuticals, Inc. v. Sandoz, Inc., No. 2007-1081, 2007 U.S. App. LEXIS 2800, 2007 WL 419358 (Fed. Cir. Jan. 25, 2007) (order dismissing proceeding).
  • Pharm. Res., Inc. v. Roxane Labs. Inc., No. 03-3357, 2006 U.S. Dist. LEXIS 81628, 2006 WL 3231427 (D.N.J. Nov. 8, 2006).
  • Dey LP v. IVAX Pharm. Inc., 233 F.R.D. 567 (C.D. Cal. 2005).
  • Novartis Pharm. Corp. v. Eon Labs Mfg., Inc., 363 F.3d 1306 (Fed. Cir. 2004).
  • In re Les Halles De Paris J.V., 334 F.3d 1371 (Fed. Cir. 2003).
  • Nadel v. Isaksson, 321 F.3d 266 (2d Cir. 2003).
  • Well-Made Toy Mfg., Corp. v. Goffa Int'l Corp., 354 F.3d 112 (2d Cir. 2003).
  • Glaxo Wellcome Inc., v. Eon Labs Mfg., Inc., No. 00-Civ-9089, 2003 U.S. Dist LEXIS 14680, 2003 WL 22004874 (S.D.N.Y. Aug. 22, 2003).
  • In re Omeprazole Patent Litigation, 265 F. Supp. 2d 213 (S.D.N.Y. 2003).
  • Elite Licensing, Inc. v. Thomas Plastics, Inc., 250 F. Supp. 2d 372 (S.D.N.Y. 2003).
  • In re '639 Patent Litigation 154 F. Supp. 2d 157 (D. Mass. 2001), aff''d sub. nom. SmithKline Beecham Corp. v. Copley Pharm., No. 01-1611, 45 Fed. Appx. 915 (Fed. Cir. Aug. 15, 2002).
  • Well-Made Toy Mfg., Corp. v. Goffa Int'l Corp., 210 F. Supp. 2d 147 (E.D.N.Y. 2002).
  • Glaxo Wellcome Inc., v. Eon Labs Mfg., Inc., No. 00-Civ-9089, 2002 U.S. Dist. LEXIS 14950, 2002 WL 1874831 (S.D.N.Y. Aug. 13, 2002).
  • Bristol-Myers Squibb Co. v. Ben Venue Labs., Inc., 246 F.3d 1368 (Fed. Cir. 2001).
  • Nadel v. Play-By-Play Toys & Novelties, Inc., 208 F.3d 368 (2d Cir. 2000).
  • Ideal World Marketing Inc. v. Duracell Inc., 997 F. Supp. 334 (E.D.N.Y. 1998).
  • Valmet Paper Mach. Inc. v. Beloit Corp., 105 F.3d 1409 (Fed. Cir. 1997).
  • Thermalloy, Inc. v. Aavid Eng'g, Inc., 121 F.3d 691 (Fed. Cir. 1997).
  • Bayer AG v. Barr Laboratories, Inc., No. 92-Civ-0381, 1996 U.S. Dist. LEXIS 13032, 1996 WL 509714 (S.D.N.Y. 1996).
  • Glaxo Inc., Glaxo Group Limited, and Allen and Hanburys Limited v. Boehringer Ingelheim Corporation, and Boehringer Ingelheim Chemicals, Inc., 40 U.S.P.Q.2D 1848 (D.Conn. 1996).
  • Glaxo Inc., Glaxo Group Limited, and Hanburys Limited v. Boehringer Ingelheim Corporation and Boehringer Ingelheim Chemicals, Inc., 954 F. Supp. 469, 41 U.S.P.Q.2D 1445 (D.Conn. 1996).
  • Godinger Silver Art Co., Ltd. v. Int'l Silver Co. Inc., No. 95-Civ-9199, 1995 U.S. Dist LEXIS 17696, 1995 WL 702357 (S.D.N.Y. 1995).
  • Imperial Chem. Indus., PLC, v. Barr Labs., 795 F. Supp. 619 (S.D.N.Y. 1992).
  • Wallace Int'l Silversmiths, Inc. v. Godinger Silver Art Co., Inc., 916 F.2d 76 (2d Cir. 1990).
    •  

    Press Releases
  • Cohen Pontnai Lieberman & Pavane Partners Martin Pavane & Edward Weisz brief the 6th Annual Asia-Pacific IP Forum on Defending IP in the US - October 2009
  • Cohen Pontani Lieberman & Pavane Prevails in Cybersquatting Action - October 2009
  • CPLP Stops “Bad” C.A.T.’s Patent Infringement; Wins Significant Damages Award for Client Hypoxico - February 2009
  • CPLP Partner Alan J. Morrison to Contribute to New Book on Antibody Engineering - December 2008
  • CPLP successfully Challenges a U.S. Patent on Behalf of Client in a USPTO Reexamination Proceeding - August 2008
  • Order Denying a Temporary Restraining Order and Granting an Order to Show Cause – US District Court Central District of CA Case No SACV 08-0635 AG - June 2008
  • Alan Tenebaum Joins Cohen Pontani Lieberman & Pavane LLP in New York City as a Partner - May 2008
  • Alfred W. Froebrich Named Partner at Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008
  • Julia S. Kim Named Partner at Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008
  • Lisa A Ferrari Named Partner at Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008
  • Marilyn Neiman Joins Cohen Pontani Lieberman & Pavane LLP in New York City - May 2008
  • CPLP Alert: U.S. Patent and Trademark Office Final Rule Held Void - April 8, 2008
  • CPLP Alert: Implementation of the Final Rule by the USPTO has been enjoined - November 7, 2007
  • CPLP Partner Thomas Langer Briefs French ASPI on the Impact of New USPTO Regulations
  • CPLP Alert: The Final Rule and Its Effect on U.S. Patent Practice – CPLP has identified tactical approaches and outlined recommendations for complying with the USPTO “Final Rule.”
  • CPLP Alert: Changes to U.S. patent practice – The USPTO “Final Rule” is scheduled to become effective November 1, 2007.
  • Alan J. Morrison Joins Cohen Pontani Lieberman & Pavane